Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
Back to Search Results

Connection

Search Results to Martin Cannon

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following items that are connected to Cannon, Martin

Item TypeName
Academic Article Restoration of tumor-specific HLA class I restricted cytotoxicity in tumor infiltrating lymphocytes of advanced breast cancer patients by in vitro stimulation with tumor antigen-pulsed autologous dendritic cells.
Academic Article Induction of tumor-specific cytotoxicity in tumor infiltrating lymphocytes by HPV16 and HPV18 E7-pulsed autologous dendritic cells in patients with cancer of the uterine cervix.
Academic Article Therapeutic vaccines for cervical cancer: dendritic cell-based immunotherapy.
Academic Article Immunological treatment of ovarian cancer.
Academic Article HPV16/18 E7-pulsed dendritic cell vaccination in cervical cancer patients with recurrent disease refractory to standard treatment modalities.
Academic Article Cellular immunotherapy for ovarian cancer.
Academic Article Immune surveillance as a rationale for immunotherapy?
Academic Article Understanding the cross-talk between ovarian tumors and immune cells: mechanisms for effective immunotherapies.
Academic Article Generation of CA125-specific cytotoxic T lymphocytes in human leukocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
Academic Article Vaccination with HPV-18 E7-pulsed dendritic cells in a patient with metastatic cervical cancer.
Academic Article Combinatorial strategies for alleviation of tumor-associated immune suppression and therapeutic vaccination against ovarian cancer.
Academic Article Identification of AKAP-4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancer.
Academic Article Cancer testis antigen, ropporin, is a potential target for multiple myeloma immunotherapy.
Academic Article Novel target antigens for dendritic cell-based immunotherapy against ovarian cancer.
Academic Article Prospects and challenges for immunotherapy of ovarian cancer--what can we learn from the tumor microenvironment?
Academic Article The case for HER2/neu as a therapeutic target for gynecologic malignancies.
Concept Immunotherapy
Concept Immunotherapy, Adoptive
Concept Immunotherapy, Active
Academic Article Intrathecal cytotoxic T cell immunotherapy for metastic leptomeningeal melanoma
Academic Article T CELL RECOGNITION OF MULTI-EPITOPE REGIONS WITHIN THE OVARIAN TUMOR ANTIGENS MATRIPTASE AND STRATUM CORNEUM CHYMOTRYPTIC ENZYME. SUBMITTED, J. IMMUNOTHERAPY
Academic Article Cancer testis antigen Sperm autoantigenic protein 17 as a new target for breast cancer immunotherapy. In preparation
Academic Article The HPV 16 E6 52-61 CD8 T cell epitope as a source of antigen for dendritic cell immunotherapy for cervical cancer
Academic Article Cellular immunotherapy and immune regulation in ovarian cancer
Academic Article Induction of tumor-specific CD8+ lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells in patients with advanced ovarian cancer
Academic Article Treatment of a patient with metastatic leptomeningeal melanoma by injection of autologous cytotoxic T cells
Academic Article Defining and managing expectations for early immunotherapy cancer trials.
Grant Dendritic cell immunotherapy for ovarian cancer
Grant Novel target antigens for ovarian cancer immunotherapy
Grant T-CELL IMMUNOTHERAPY OF EBV ASSOCIATED LYMPHOMA
Grant CD 8+ Cytotoxic T Cell Responses to Novel Ovarian Cancer Antigens (immunotherapy, ovarian cancer, gynecologic oncology, cytotoxic T lymphocytes, dendr
Academic Article The evolving clinical landscape for dendritic cell vaccines and cancer immunotherapy.
Academic Article Repurposing live attenuated trivalent MMR vaccine as cost-effective cancer immunotherapy.
Grant Improvement of cellular immunotherapy during dysbiosis
Grant Improvement of cellular immunotherapy during dysbiosis
Grant Mechanisms of Th17-DC immunotherapy for ovarian cancer

Search Criteria
  • Immunotherapy